About Mesa Biotech
Mesa Biotech is a company based in San Diego (United States) founded in 2009 was acquired by Thermo Fisher Scientific in January 2021.. Mesa Biotech has raised $26.8 million across 7 funding rounds from investors including Thermo Fisher Scientific, Public Health Emergency and NIH SBIR/STTR. The company has 131 employees as of December 31, 2020. Mesa Biotech offers products and services including Antibodies, Cell Culture Media, Chromatography Columns, and TaqMan Real-Time PCR Assays. Mesa Biotech operates in a competitive market with competitors including Inflammatix, Karius, Ansa Biotechnologies, Nuclera Nucleics and MeMed, among others.
- Headquarter San Diego, United States
- Employees 131 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$26.8 M (USD)
in 7 rounds
-
Latest Funding Round
$13 M (USD), Grant
Nov 06, 2020
-
Investors
Thermo Fisher Scientific
& 2 more
-
Employee Count
131
as on Dec 31, 2020
-
Acquired by
Thermo Fisher Scientific
(Jan 19, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mesa Biotech
Mesa Biotech offers a comprehensive portfolio of products and services, including Antibodies, Cell Culture Media, Chromatography Columns, and TaqMan Real-Time PCR Assays. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tools for protein detection in research and diagnostics applications.
Nutrient solutions for growing cells in laboratory settings.
Components for separating mixtures in chemical analysis.
Kits for detecting genetic material in testing scenarios.
Unlock access to complete
Unlock access to complete
Funding Insights of Mesa Biotech
Mesa Biotech has successfully raised a total of $26.8M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $13 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $13.0M
-
First Round
First Round
(19 Oct 2011)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Grant - Mesa Biotech | Valuation |
investors |
|
| Oct, 2019 | Amount | Series B - Mesa Biotech | Valuation |
investors |
|
| Jul, 2018 | Amount | Series B - Mesa Biotech | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mesa Biotech
Mesa Biotech has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Thermo Fisher Scientific, Public Health Emergency and NIH SBIR/STTR. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Electron microscopy services and microanalysis instruments are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mesa Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mesa Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mesa Biotech Comparisons
Competitors of Mesa Biotech
Mesa Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, Ansa Biotechnologies, Nuclera Nucleics and MeMed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
DNA synthesis technology using enzymes is provided.
|
|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mesa Biotech
Frequently Asked Questions about Mesa Biotech
When was Mesa Biotech founded?
Mesa Biotech was founded in 2009 and raised its 1st funding round 2 years after it was founded.
Where is Mesa Biotech located?
Mesa Biotech is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Mesa Biotech a funded company?
Mesa Biotech is a funded company, having raised a total of $26.8M across 7 funding rounds to date. The company's 1st funding round was a Series B of $20M, raised on Oct 19, 2011.
How many employees does Mesa Biotech have?
As of Dec 31, 2020, the latest employee count at Mesa Biotech is 131.
What does Mesa Biotech do?
Mesa Biotech was founded in 2009 in San Diego, United States, and operates in the molecular diagnostics sector. Point-of-care kits are provided through a reusable dock and disposable cassettes, enabling detection of pathogens and genetic targets in settings such as physicians offices or homes. The system supports multiplexed testing for human, agricultural, and food applications, with hardware designed for sensitivity and specificity comparable to lab-based methods.
Who are the top competitors of Mesa Biotech?
Mesa Biotech's top competitors include Visby Medical, Nuclera Nucleics and Inflammatix.
What products or services does Mesa Biotech offer?
Mesa Biotech offers Antibodies, Cell Culture Media, Chromatography Columns, and TaqMan Real-Time PCR Assays.
Who are Mesa Biotech's investors?
Mesa Biotech has 3 investors. Key investors include Thermo Fisher Scientific, Public Health Emergency, and NIH SBIR/STTR.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.